Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand

AIDS Res Hum Retroviruses. 2009 Nov;25(11):1083-9. doi: 10.1089/aid.2009.0055.

Abstract

This study analyzes immunologic markers to predict and diagnose tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in HIV and TB coinfected adults who initiated antiretroviral therapy (ART) in Thailand. T helper 1 cytokines interleukin (IL)-2, IL-12, and interferon-gamma (IFN-gamma) levels in response to PPD and RD1 antigens were assessed prior to ART, at weeks 6, 12, and 24 of treatment, and at time of TB-IRIS. Of 126 subjects, 22 (17.5%) developed TB-IRIS; 14 (64%) subjects received steroid treatment and 3 (14%) received NSAIDs; none of the subjects died. Median interval between ART initiation and TB-IRIS development was 14 days. IFN-gamma, IL-2, and IL-12 responses did not differ between TB-IRIS and no TB-IRIS subjects (p > 0.05). More research into the immunopathogenesis of TB-IRIS and diagnostic potential of cytokine markers is warranted.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections* / drug therapy
  • AIDS-Related Opportunistic Infections* / epidemiology
  • AIDS-Related Opportunistic Infections* / immunology
  • AIDS-Related Opportunistic Infections* / microbiology
  • Adult
  • Antiretroviral Therapy, Highly Active
  • Antitubercular Agents / therapeutic use
  • Biomarkers / blood*
  • Cytokines / blood*
  • Female
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • HIV Infections* / epidemiology
  • HIV Infections* / immunology
  • Humans
  • Immune Reconstitution Inflammatory Syndrome* / epidemiology
  • Immune Reconstitution Inflammatory Syndrome* / immunology
  • Immune Reconstitution Inflammatory Syndrome* / physiopathology
  • Male
  • Predictive Value of Tests
  • Th1 Cells / immunology
  • Th1 Cells / metabolism
  • Thailand / epidemiology
  • Treatment Outcome
  • Tuberculosis* / complications
  • Tuberculosis* / drug therapy
  • Tuberculosis* / epidemiology
  • Tuberculosis* / immunology

Substances

  • Antitubercular Agents
  • Biomarkers
  • Cytokines